Sommario
Grazie al progresso delle terapie oncologiche, il numero di giovani adulti guariti da tumori dell’età pediatrica (i cosiddetti childhood cancer survivors) è in costante aumento. Numerose evidenze dimostrano che questi soggetti possono andare incontro all’insorgenza precoce di patologie, soprattutto cardiovascolari e oncologiche, tipiche dell’età avanzata, facendo ipotizzare che le terapie anti-tumorali possano determinare un’accelerazione dei fisiologici meccanismi di invecchiamento. Questa rassegna riassume le principali evidenze sul ruolo dell’infiammazione cronica all’interno dei meccanismi di ageing prematuro che caratterizzano i childhood cancer survivors.
Abstract
Thanks to the improvements in cancer treatment protocols, the number of childhood cancer survivors within the general population is constantly increasing. Several studies showed that these patients can prematurely experience health conditions (e.g., cardiovascular diseases, cancer) that usually affect older people. Therefore, it has been hypothesised that anticancer therapies can accelerate the development of physiological mechanism of senescence. This review summarises the recent evidence about the role of chronic low grade inflammation in the onset of premature ageing in survivors of childhood cancer.
Bibliografia
Howlader N, Noone AM, Krapcho M (2015) SEER Cancer Statistics Review (CSR) 1975–2013. National Cancer Institute, Bethesda
Felicetti F, Fortunati N, Biasin E et al. (2014) Complicanze endocrine a lungo temine nei cancer survivors. Endocrinologo 15(3):123–129
Oeffinger KC, Mertens AC, Sklar CA et al. (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572–1582
Armstrong GT, Liu Q, Yasui Y et al. (2009) Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 27:2328–2338
de Haas EC, Oosting SF, Lefrandt JD et al. (2010) The metabolic syndrome in cancer survivors. Lancet Oncol 11:193–203
Bhakta N, Liu Q, Ness KK et al. (2017) The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Lancet 390(10112):2569–2582
Armstrong GT, Kawashima T, Leisenring W et al. (2014) Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol 32:1218–1227
Liberale L, Badimon L, Montecucco F et al. (2022) Inflammation, aging, and cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol 79(8):837–847
Dugan B, Conway J, Duggal NA (2023) Inflammaging as a target for healthy ageing. Age Ageing 52(2):afac328
Tabibzadeh S (2021) Signaling pathways and effectors of aging. Front Biosci 26(1):50–96
Vistoli G, De Maddis D, Cipak A et al. (2013) Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res 47(Suppl 1):3–27
Twarda-Clapa A, Olczak A, Białkowska AM et al. (2022). Advanced Glycation End-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs. Cells 11(8):1312
Dong H, Zhang Y, Huang Y et al. (2022) Pathophysiology of RAGE in inflammatory diseases. Front Immunol 13:931473
Tóbon-Velasco JC, Cuevas E, Torres-Ramos MA (2014) Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets 13(9):1615–1626
Hollenbach M (2017) The role of glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and their receptor (RAGE) in chronic liver disease and hepatocellular carcinoma (HCC). Int J Mol Sci 18(11):2466
Armenian SH, Gibson CJ, Rockne RC et al. (2019) Premature aging in young cancer survivors. J Natl Cancer Inst 111:226–232
Ness KK, Armstrong GT, Kundu M et al. (2015) Frailty in childhood cancer survivors. Cancer 121:1540–1547
Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15:505–522
Latoch E, Konończuk K, Konstantynowicz-Nowicka K et al. (2022) Asymptomatic survivors of childhood acute lymphoblastic leukemia demonstrate a biological profile of inflamm-aging early in life. Cancers 14(10):2522
Felicetti F, Cento AS, Fornengo P et al. (2020) Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation. Pediatr Blood Cancer 67(3):e28106
Felicetti F, Dal Aimaretti E, Bello F et al. (2022) Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: a possible role in the onset of late complications. Free Radic Biol Med 178:76–82
Rossi F, Di Paola A, Pota E (2021) Biological aspects of inflamm-aging in childhood cancer survivors. Cancers 19:4933
Sulicka-Grodzicka J, Surdacki A, Seweryn M et al. (2021) Low-grade chronic inflammation and immune alterations in childhood and adolescent cancer survivors: a contribution to accelerated aging?. Cancer Med 10(5):1772–1782
Ariffin H, Azanan MS, Abd Ghafar SS et al. (2017) Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging. Cancer 123:4207–4214
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflitto di interesse
Gli autori Francesco Felicetti, Eleonora Aimaretti, Nicoletta Fortunati, Filippo Gatti, Eleonora Biasin, Franca Fagioli, Manuela Aragno e Emanuela Arvat dichiarano di non avere conflitti di interesse.
Consenso informato
Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.
Studi sugli animali
Gli autori di questo articolo non hanno eseguito studi sugli animali.
Additional information
Proposto da E. Arvat.
Nota della casa editrice
Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.
Informazioni Supplementari
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Felicetti, F., Aimaretti, E., Fortunati, N. et al. Childhood cancer survivors, infiammazione e invecchiamento precoce. L'Endocrinologo 25, 196–202 (2024). https://doi.org/10.1007/s40619-024-01438-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40619-024-01438-3